Wood Christopher S, Koepke Jay I, Teng Hua, Boucher Krissy K, Katz Sharon, Chang Patrick, Terlecky Laura J, Papanayotou Irene, Walton Paul A, Terlecky Stanley R
Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Traffic. 2006 Jan;7(1):97-107. doi: 10.1111/j.1600-0854.2005.00358.x.
Human epidemiological studies point to an association of hypocatalasemia and an increased risk of age-related disease. Unfortunately, the cellular and molecular manifestations of hypocatalasemia are only poorly understood. In this analysis, we have extensively characterized hypocatalasemic human fibroblasts and report that they amass hydrogen peroxide and are oxidatively damaged. Protein and DNA alike are affected, as are functioning and biogenesis of peroxisomes - the subcellular organelles which normally house catalase. Despite these pathologies and their relative inability to grow, the cells do not appear to be intrinsically senescent. With the goal of restoring oxidative balance and perhaps reversing some of the accumulated damage to critical cellular components, we transduced hypocatalasemic fibroblasts with a form of catalase specifically designed to efficiently traffic to peroxisomes. We show the strategy is extremely effective, with dramatic reductions seen in cellular hydrogen peroxide levels. Future longitudinal studies aimed at examining the effects of a more continuous and long-term protein therapy may now commence.
人类流行病学研究表明,过氧化氢酶缺乏症与年龄相关疾病风险增加之间存在关联。不幸的是,人们对过氧化氢酶缺乏症的细胞和分子表现了解甚少。在本分析中,我们对过氧化氢酶缺乏症患者的成纤维细胞进行了广泛的特征分析,并报告称这些细胞会积累过氧化氢并受到氧化损伤。蛋白质和DNA均受到影响,过氧化物酶体(通常含有过氧化氢酶的亚细胞器)的功能和生物发生也受到影响。尽管存在这些病理状况且它们相对无法生长,但这些细胞似乎并非内在衰老。为了恢复氧化平衡并可能逆转对关键细胞成分的一些累积损伤,我们用一种专门设计用于有效转运至过氧化物酶体的过氧化氢酶形式转导过氧化氢酶缺乏症成纤维细胞。我们表明该策略极其有效,细胞内过氧化氢水平显著降低。现在可以开展旨在研究更持续和长期蛋白质疗法效果的未来纵向研究了。